Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in…